Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
China flag China · Delayed Price · Currency is CNY
10.16
-0.16 (-1.55%)
May 12, 2026, 3:00 PM CST

SHA:603229 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,1501,2231,0961,124608.85564.55
Trading Asset Securities
3.873.942.24-4.02110
Cash & Short-Term Investments
1,1541,2271,0991,124612.87674.55
Cash Growth
3.95%11.65%-2.29%83.44%-9.14%-8.73%
Accounts Receivable
321.31146.41196.58132.75134.8166.24
Other Receivables
1.961.791.632.828.491.49
Receivables
323.26148.2198.21135.57143.367.73
Inventory
367.83398.3400.95365.18320.57243.44
Other Current Assets
34.1742.3211.4849.7559.9734.86
Total Current Assets
1,8791,8151,7091,6751,1371,021
Property, Plant & Equipment
1,0381,0371,0411,046950.94601.46
Long-Term Investments
72.9172.5672.5667.3750.1432.64
Other Intangible Assets
150.56151.56155.39150.37161.98164.2
Long-Term Deferred Tax Assets
5.743.820.46-6.874.47
Other Long-Term Assets
10.895.353.9912.718.6916.1
Total Assets
3,1573,0852,9822,9522,3151,839
Accounts Payable
225.01270.1351.64410.85519.32402.25
Accrued Expenses
21.8342.2446.8740.1142.9131.63
Short-Term Debt
440.67410.61270.31300.26160.1265.07
Current Portion of Long-Term Debt
1.561.79--9.16-
Current Portion of Leases
--1.040.87--
Current Income Taxes Payable
16.317.852.5310.21-5.81
Current Unearned Revenue
1.10.960.917.0612.6323.23
Other Current Liabilities
4.62.471.231.611.282.33
Total Current Liabilities
711.09736.02674.53770.97745.42530.32
Long-Term Debt
43.9944.25--72.7444.86
Long-Term Leases
--1.082.04--
Long-Term Unearned Revenue
34.5735.6234.8934.9123.519.46
Long-Term Deferred Tax Liabilities
---2.0712.51-
Total Liabilities
789.65815.89710.5809.99854.19584.64
Common Stock
830.3830.3830.3593.07401.87287.05
Additional Paid-In Capital
440.23440.23440.23677.45394.72509.54
Retained Earnings
1,1471,0501,002871.92665.46459.36
Treasury Stock
-50.01-50.01----
Comprehensive Income & Other
-0.81-1.1-0.83-0.86-0.91-1.14
Shareholders' Equity
2,3672,2692,2722,1421,4611,255
Total Liabilities & Equity
3,1573,0852,9822,9522,3151,839
Total Debt
486.22456.65272.43303.17242.02109.93
Net Cash (Debt)
667.38769.86826.1821.06370.85564.62
Net Cash Growth
-18.39%-6.81%0.61%121.40%-34.32%-19.12%
Net Cash Per Share
0.830.941.001.000.460.71
Filing Date Shares Outstanding
805.52779.87828.3830.3787.66787.66
Total Common Shares Outstanding
805.52779.87830.3830.3787.66787.66
Working Capital
1,1681,0791,035903.76391.28490.26
Book Value Per Share
2.942.912.742.581.861.59
Tangible Book Value
2,2172,1182,1161,9911,2991,091
Tangible Book Value Per Share
2.752.722.552.401.651.38
Buildings
--261.11224.84168.11150.71
Machinery
--559.12510.1278.07223.16
Construction In Progress
--495.66526.23685.01379.24
Source: S&P Global Market Intelligence. Standard template. Financial Sources.